Thompson DA, Ng R, Dawson PE. Arginine selective reagents for ligation to peptides and proteins. J Pept Sci. 2016 May;22(5):311-9. doi: 10.1002/psc.2867. Epub 2016 Mar 22. abstract

    Thompson DA, Evans EG, Kasza T, Millhauser GL, Dawson PE. Adapter reagents for protein site specific dye labeling. Biopolymers:Peptide Science. 2014 May 22;102(3):273-279. abstract

    Boeneman K, Delehanty JB, Blanco-Canosa JB, Susumu K, Stewart MH, Oh E, Huston AL, Dawson G, Ingale S, Walters R, Domowicz M, Deschamps JR, Algar WR, Dimaggio S, Manono J, Spillmann CM, Thompson D, Jennings TL, Dawson PE, Medintz IL. Selecting improved peptidyl motifs for cytosolic delivery of disparate protein and nanoparticle materials. ACS Nano. 2013 May 28;7(5):3778-96. abstract

    Ersoy BA, Pardo L, Zhang S, Thompson DA, Millhauser G, Govaerts C, Vaisse C. Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR. Nature Chemical Biology 2012 Jun 24;8(8):725-730. abstract

    Zhang C, Song Y, Thompson DA, Madonna MA, Millhauser GL, Toro S, Varga Z, Westerfield M, Gamse J, Chen W, Cone RD. Pineal-specific agouti protein regulates teleost background adaptation. Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20164-71. abstract

    Sánchez E, Rubio VC, Thompson DA, Metz J, Flik G, Millhauser GL, Cerda-Reverter JM. PHOSPHODIESTERASE INHIBITOR-DEPENDENT INVERSE AGONISM OF AGOUTI-RELATED PROTEIN (AGRP) ON MELANOCORTIN 4 RECEPTOR IN SEA BASS (Dicentrarchus labrax). Am J Physiol Regul Integr Comp Physiol. 2009 May;296(5):R1293-306. abstract

    Kaelin CB, Candille SI, Yu B, Jackson P, Thompson DA, Nix MA, Binkley J, Millhauser GL, Barsh GS. New ligands for melanocortin receptors. Int J Obes (Lond). 2008 Dec;32 Suppl 7:S19-27. abstract

    Candille SI, Kaelin CB, Cattanach BM, Yu B, Thompson DA, Nix MA, Kerns JA, Schmutz SM, Millhauser GL, Barsh GS. A {beta}-Defensin Mutation Causes Black Coat Color in Domestic Dogs. Science. 2007 Nov 30;318(5855):1418-23. abstract

    Lee YS, Challis BG, Thompson DA, Yeo GS, Keogh JM, Madonna ME, Wraight V, Sims M, Vatin V, Meyre D, Shield J, Burren C, Ibrahim Z, Cheetham T, Swift P, Blackwood A, Hung CC, Wareham NJ, Froguel P, Millhauser GL, O'Rahilly S, Farooqi IS. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 2006 Feb;3(2):135-40. abstract

    Jackson PJ, Yu B, Hunrichs B, Thompson DA, Chai B, Gantz I, Millhauser GL.
    Chimeras of the agouti-related protein: Insights into agonist and antagonist selectivity of melanocortin receptors. Peptides. 2005 Oct;26(10):1978-87. abstract

    McNulty JC, Jackson PJ, Thompson DA, Chai B, Gantz I, Barsh GS, Dawson PE, Millhauser GL. Structures of the agouti signaling protein. J Mol Biol. 2005 Mar 4;346(4):1059-70. abstract

    Hartley O, Gaertner H, Wilken J, Thompson D, Fish R, Ramos A, Pastore C, Dufour B, Cerini F, Melotti A, Heveker N, Picard L, Alizon M, Mosier D, Kent S, Offord R. Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors. Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16460-5. abstract

    Chai BX, Neubig RR, Millhauser GL, Thompson DA, Jackson PJ, Barsh GS, Dickinson CJ, Li JY, Lai YM, Gantz I. Inverse agonist activity of agouti and agouti-related protein. Peptides. 2003 Apr;24(4):603-9. abstract

    Millhauser GL, McNulty JC, Jackson PJ, Thompson DA, Barsh GS, Gantz I. Loops and links: structural insights into the remarkable function of the agouti-related protein. Ann N Y Acad Sci. 2003 Jun;994:27-35. Review. abstract

    Thompson DA, Chai B, Rood HLE, Siani MA, Douglas NR, Gantz I, Millhauser GL. Peptoid mimics of agouti related protein. Bioorg Med Chem Lett 2003 April 17, 13(8):1409-1413. abstract

    McNulty J, Thompson D, Carrasco M, Millhauser G.Dap-SL: a new site-directed nitroxide spin labeling approach for determining structure and motions in synthesized peptides and proteins. FEBS Lett. 2002 Oct 9;529(2-3):243. abstract

    Jackson PJ, McNulty JC, Yang YK, Thompson DA, Chai B, Gantz I, Barsh GS, Millhauser GL. Design, Pharmacology, and NMR Structure of a Minimized Cystine Knot with Agouti-Related Protein Activity. Biochemistry. 2002 Jun 18;41(24):7565-72. abstract

    McNulty JC, Thompson DA, Bolin KA, Wilken J, Barsh GS, Millhauser GL. High-Resolution NMR Structure of the Chemically-Synthesized Melanocortin Receptor Binding Domain AGRP(87-132) of the Agouti-Related Protein. Biochemistry. 2001 Dec 25;40(51):15520-15527. abstract

    Shao W, Fernandez E, Sachpatzidis A, Wilken J, Thompson DA, Schweitzer BI, Lolis E. CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structure. Eur J Biochem. 2001 May;268(10):2948-2959. abstract

    Fernandez EJ, Wilken J, Thompson DA, Peiper SC, Lolis E. Comparison of the Structure of vMIP-II with Eotaxin-1, RANTES, and MCP-3 Suggests a Unique Mechanism for CCR3 Activation. Biochemistry 2000 Oct 24; 39(42): 12837-44. abstract

    Pelletier AJ, van Der Laan LJ, Hildbrand P, Siani MA, Thompson DA, Dawson PE, Torbett BE, Salomon DR. Presentation of chemokine SDF-1alpha by fibronectin mediates directed migration of T cells. Blood. 2000 Oct 15;96(8):2682-2690 abstract

    Panzer U, Schneider A, Wilken J, Thompson DA, Kent SB, Stahl RA The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis. Kidney Int 1999 Dec;56(6):2107-15 abstract

    Jordan NJ, Kolios G, Abbot SE, Sinai MA, Thompson DA, Petraki K, Westwick J Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J Clin Invest 1999 Oct 15;104(8):1061-1069 abstract

    Rusconi S, La Seta-Catamancio S, Kurtagic S, Galazzi M, Arienti D, Trabattoni D, Wilken J, Thompson DA, Offord RE, Galli M, Clerici M Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferation.
    AIDS Res Hum Retroviruses 1999 Jul 1;15(10):861-7 abstract

    Wilken J, Thompson D, Picard L, Kent SB, Hartley O, Offord RE Rational development of an anti-HIV protein active at low picomolar concentrations. (16th American Peptide Symposium Minneapolis, MI, USA June 26-July 01, 1999) Peptides for the new millennium 1999: 513-515.

    Bolin KA, Anderson DJ, Trulson JA, Thompson DA, Wilken J, Kent SB, Gantz I, Millhauser GL NMR structure of a minimized human agouti related protein prepared by total chemical synthesis. FEBS Lett 1999 May 21;451(2):125-31 abstract

    Yang YK, Dickinson CJ, Zeng Q, Li JY, Thompson DA, Gantz I Contribution of melanocortin receptor exoloops to Agouti-related protein binding. J Biol Chem 1999 May 14;274(20):14100-6 abstract

    Mosier DE, Picchio GR, Gulizia RJ, Sabbe R, Poignard P, Picard L, Offord RE, Thompson DA, Wilken J Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants. J Virol 1999 May;73(5):3544-50 abstract

    Yang YK, Thompson DA, Dickinson CJ, Wilken J, Barsh GS, Kent SB, Gantz I
    Characterization of Agouti-related protein binding to melanocortin receptors. Mol Endocrinol 1999 Jan;13(1):148-55 abstract

    Wilken J, Hoover D, Thompson DA, Barlow PN, McSparron H, Picard L, Wlodawer A, Lubkowski J, Kent SB Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES. Chem Biol 1999 Jan;6(1):43-51 abstract

    Shao W, Fernandez E, Wilken J, Thompson DA, Siani MA, West J, Lolis E, Schweitzer BI Accessibility of selenomethionine proteins by total chemical synthesis: structural studies of human herpesvirus-8 MIP-II. FEBS Lett 1998 Dec 11;441(1):77-82 abstract

    Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, Botti P, Bacon KB, Feng L Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A 1998 Sep 1;95(18):10896-901 abstract

    Chen S, Bacon KB, Li L, Garcia GE, Xia Y, Lo D, Thompson DA, Siani MA, Yamamoto T, Harrison JK, Feng L In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med 1998 Jul 6;188(1):193-8 abstract

    Campbell JJ, Bowman EP, Murphy K, Youngman KR, Siani MA, Thompson DA, Wu L, Zlotnik A, Butcher EC 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7. J Cell Biol 1998 May 18;141(4):1053-9 abstract

    Dealwis C, Fernandez EJ, Thompson DA, Simon RJ, Siani MA, Lolis E Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 "fusin" coreceptor. Proc Natl Acad Sci U S A 1998 Jun 9;95(12):6941-6 abstract

    Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC
    Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998 Jan 16;279(5349):381-4 abstract

    Trkola A, Paxton WA, Monard SP, Hoxie JA, Siani MA, Thompson DA, Wu L, Mackay CR, Horuk R, Moore JP Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
    J Virol 1998 Jan;72(1):396-404 abstract

    Davis CB, Dikic I, Unutmaz D, Hill CM, Arthos J, Siani MA, Thompson DA, Schlessinger J, Littman DR Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 1997 Nov 17;186(10):1793-8 abstract

    Ueda H, Siani MA, Gong W, Thompson DA, Brown GG, Wang JM Chemically synthesized SDF-1alpha analogue, N33A, is a potent chemotactic agent for CXCR4/Fusin/LESTR-expressing human leukocytes. J Biol Chem 1997 Oct 3;272(40):24966-70 abstract